SUBSCRIBE
SUBSCRIBE

Cingulate Therapeutics

NEWS
Drug Development
Clinical Catch-Up: 3’s the Charm for Pfizer-BioNTech Vaccine in Kids & More
A roundup of last week’s top clinical trial announcements and news, including updates from Pfizer, BioNTech, Ocugen and more.
May 27, 2022
 · 
10 min read
 · 
Mark Terry
Bio NC
Anxious? Activate Your Anterior Cingulate Cortex With a Little Meditation, Wake Forest University Baptist Medical Center Study
June 5, 2013
 · 
1 min read
JOBS
IN THE PRESS
Business
Cingulate Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Clinical and Business Update
March 10, 2022
 · 
10 min read
Cingulate to Present at Aegis Virtual Conference
February 15, 2022
 · 
1 min read
Cingulate Provides 2022 Clinical Plan for CTx-1301, an Investigational Medication for Attention Deficit/Hyperactivity Disorder (ADHD)Expedited Clinical Program Reduces Capital Requirements
February 8, 2022
 · 
5 min read
Business
Cingulate Appoints Curt Medeiros and Gregg Givens to Board of Directors
January 25, 2022
 · 
6 min read
Deals
Cingulate Inc. Announces Closing of Initial Public Offering
December 10, 2021
 · 
4 min read
Deals
Cingulate Inc. Announces Pricing of $25.0 Million Initial Public Offering
December 7, 2021
 · 
4 min read
Drug Development
Cingulate Therapeutics Presents Results of Pivotal Phase 2 Clinical Trial for Lead ADHD Candidate CTx-1301 at the American Association of Child and Adolescent Psychiatry Annual Meeting
October 26, 2020
 · 
4 min read
BioMidwest
Cingulate Therapeutics to Present at Biotech Showcase™ 2019 in San Francisco
January 7, 2019
 · 
2 min read
BDD Pharma and Cingulate Therapeutics Announce License Agreement With OralogiK™ Enabled Triple Pulse Products
September 7, 2018
 · 
3 min read
BioMidwest
Cingulate Therapeutics Announces $7.5M Equity Investment from Werth Family Investment Associates
July 11, 2018
 · 
4 min read
Load More